IT1144812B - Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione - Google Patents

Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione

Info

Publication number
IT1144812B
IT1144812B IT67863/81A IT6786381A IT1144812B IT 1144812 B IT1144812 B IT 1144812B IT 67863/81 A IT67863/81 A IT 67863/81A IT 6786381 A IT6786381 A IT 6786381A IT 1144812 B IT1144812 B IT 1144812B
Authority
IT
Italy
Prior art keywords
lattami
lyophylized
beta
procedure
preparation
Prior art date
Application number
IT67863/81A
Other languages
English (en)
Italian (it)
Other versions
IT8167863A0 (it
Inventor
Eizo Hirai
Kazuhiro Shima
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of IT8167863A0 publication Critical patent/IT8167863A0/it
Application granted granted Critical
Publication of IT1144812B publication Critical patent/IT1144812B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
IT67863/81A 1980-06-23 1981-06-22 Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione IT1144812B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (2)

Publication Number Publication Date
IT8167863A0 IT8167863A0 (it) 1981-06-22
IT1144812B true IT1144812B (it) 1986-10-29

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67863/81A IT1144812B (it) 1980-06-23 1981-06-22 Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione

Country Status (31)

Country Link
US (1) US4418058A (en:Method)
JP (1) JPS5711909A (en:Method)
KR (1) KR840000693B1 (en:Method)
AR (1) AR230007A1 (en:Method)
AT (1) AT380790B (en:Method)
AU (1) AU541627B2 (en:Method)
BE (1) BE889351A (en:Method)
BG (1) BG37991A3 (en:Method)
CA (1) CA1164801A (en:Method)
CH (1) CH648210A5 (en:Method)
CS (1) CS221835B2 (en:Method)
DD (1) DD159879A5 (en:Method)
DE (1) DE3124592A1 (en:Method)
DK (1) DK158443C (en:Method)
ES (1) ES8203887A1 (en:Method)
FI (1) FI75490C (en:Method)
FR (1) FR2484835A1 (en:Method)
GB (1) GB2078737B (en:Method)
GR (1) GR75646B (en:Method)
HU (1) HU183494B (en:Method)
IE (1) IE51331B1 (en:Method)
IL (1) IL63136A (en:Method)
IT (1) IT1144812B (en:Method)
NL (1) NL191777C (en:Method)
NO (1) NO156036C (en:Method)
NZ (1) NZ197414A (en:Method)
PT (1) PT73239B (en:Method)
RO (1) RO82720B (en:Method)
SE (1) SE460702B (en:Method)
YU (1) YU44416B (en:Method)
ZA (1) ZA814203B (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
BR0112417A (pt) * 2000-07-13 2003-07-01 Daiichi Seiyaku Co Composições farmacêuticas contendo composto dds
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
ES2800603T3 (es) 2013-09-09 2021-01-04 Merck Sharp & Dohme Tratamiento de infecciones con ceftolozano/tazobactam en sujetos con insuficiencia renal
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (en:Method) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
ZA777493B (en) * 1976-12-17 1978-10-25 Scherico Ltd Improvements in or relating to antibiotic formulations
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
AU7209781A (en) 1983-01-06
AT380790B (de) 1986-07-10
BG37991A3 (en) 1985-09-16
GR75646B (en:Method) 1984-08-02
FR2484835A1 (fr) 1981-12-24
NL191777C (nl) 1996-08-02
SE460702B (sv) 1989-11-13
SE8103904L (sv) 1981-12-24
ATA278881A (de) 1985-12-15
NO156036C (no) 1987-07-15
YU157381A (en) 1984-10-31
RO82720B (ro) 1984-07-30
DK274981A (da) 1981-12-24
PT73239B (en) 1982-07-22
IE811347L (en) 1981-12-23
CS221835B2 (en) 1983-04-29
NZ197414A (en) 1984-10-19
JPS6364405B2 (en:Method) 1988-12-12
DK158443B (da) 1990-05-21
NL191777B (nl) 1996-04-01
ES503283A0 (es) 1982-04-01
IT8167863A0 (it) 1981-06-22
RO82720A (ro) 1984-05-23
PT73239A (en) 1981-07-01
US4418058A (en) 1983-11-29
ZA814203B (en) 1982-09-29
ES8203887A1 (es) 1982-04-01
JPS5711909A (en) 1982-01-21
KR840000693B1 (ko) 1984-05-21
FI811948L (fi) 1981-12-24
KR830005848A (ko) 1983-09-14
DE3124592A1 (de) 1982-02-11
DE3124592C2 (en:Method) 1990-12-20
AU541627B2 (en) 1985-01-17
DK158443C (da) 1990-10-08
BE889351A (fr) 1981-10-16
AR230007A1 (es) 1984-02-29
NO156036B (no) 1987-04-06
YU44416B (en) 1990-08-31
DD159879A5 (de) 1983-04-13
CA1164801A (en) 1984-04-03
IE51331B1 (en) 1986-12-10
FI75490B (fi) 1988-03-31
FR2484835B1 (en:Method) 1983-07-01
GB2078737A (en) 1982-01-13
IL63136A (en) 1984-07-31
NL8102943A (nl) 1982-01-18
CH648210A5 (de) 1985-03-15
GB2078737B (en) 1984-03-14
NO812090L (no) 1981-12-28
IL63136A0 (en) 1981-09-13
FI75490C (fi) 1988-07-11
HU183494B (en) 1984-05-28

Similar Documents

Publication Publication Date Title
LV5376A3 (lv) Smekejamais izstradajums
GB2110083B (en) Visually clear coloured dentifrice
IT1144812B (it) Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione
IT1212411B (it) Antibiotico a/16686 e procedimento per la sua preparazione.
AT381878B (de) Stranggiesskokille
DK548285D0 (da) Belaegningssammensaetning
DK80785A (da) Bageform
AU548337B2 (en) Dentifrice composition
JPS57119998A (en) Shampoo composition
AT374386B (de) Stranggiesskokille
BR8206703A (pt) Composicoes pesticidas e processo de preparacao
IT1119917B (it) Composto antibatterico e procedimento per la sua preparazione
GB2099701B (en) Insect pesticidal composition
IT1197433B (it) Composizioni antibatteriche e anticoccidiche e procedimento per la loro preparazione
AU4616485A (en) Gate catch
GB8529182D0 (en) Antibacterial preparations
IT1182223B (it) Formulazione fungicida
IT1141052B (it) Composto ad attivita' antibatterica e procedimento per la sua preparazione
IT1133647B (it) Composto ad attivita' antibatterica e procedimento per la sua preparazione
IT8162004U1 (it) Rullo per l'applicazioine di colore
IT8435882V0 (it) Self-service croissants
BR6600366U (pt) Lapis-estojo de cor
IL84057A0 (en) Novel organic compounds and their preparation
BR8102700A (pt) Codificador hdb 3/ami
ATE50691T1 (de) Stabilisiertes muschelpraeparat.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950630